CAS RN: 890092-19-0
4-(4-ACETYLPIPERAZIN-1-YL)BENZALDEHYDE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250415
100mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 890092-19-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Hong Kong
Inquiry
890092-19-0 / 4-(4-acetylpiperazin-1-yl)benzaldehyde
Standard CAS: 890092-19-0
Multi CAS: No
Basic Information
copy
CAS
890092-19-0 copy
Multi CAS
No copy
Molecular Formula
C13H16N2O2 copy
Molecular Weight
232.280000 copy
Exact Mass
232.121178 copy
InChI
InChI=1S/C13H16N2O2/c1-11(17)14-6-8-15(9-7-14)13-4-2-12(10-16)3-5-13/h2-5,10H,6-9H2,1H3 copy
InChIKey
DYRIBKWUSUQUNN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.38 copy
Rotatable bonds
2 copy
H-bond acceptors
3 copy
Molar refractivity
66.3 copy
TPSA
40.62 copy
LogP / Solubility
WLOGP
1.17 copy
MLOGP
1.03 copy
XLogP3
0.8 copy
Consensus LogP
1 copy
Log S (ESOL)
-2.14 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.31 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.38 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.31 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy